Search

everythinglearnresearchcommunity

for

Search:↓

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Green tea's EGCG has various health benefits, including antioxidant properties, skin protection, cancer cell growth inhibition, anti-inflammatory effects, fat breakdown, detoxification, diabetes management, hair growth stimulation, and prevention of gum disease.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Researchers found 19 genes important for root hair growth in a plant called Arabidopsis.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Involucrin gene expression is controlled by specific proteins and signaling pathways.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

MIM is crucial for hair follicle formation and regeneration by controlling cilia formation and hedgehog signaling through its interaction with Cortactin and Src.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Prostaglandin F2alpha and related compounds can increase hair growth and darken hair in mice.

Topical Ruxolitinib may safely treat severe hair loss.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

The Foxn1 gene mutation causes hairlessness and immune system issues, and understanding it could lead to hair growth disorder treatments.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Maintaining DNA health in stem cells is key to preventing aging and tissue breakdown.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.